Vladislav Glinsky
Vladislav Glinsky
Verified email at missouri.edu
Title
Cited by
Cited by
Year
Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium
VV Glinsky, GV Glinsky, OV Glinskii, VH Huxley, JR Turk, VV Mossine, ...
Cancer research 63 (13), 3805-3811, 2003
3032003
The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium
VV Glinsky, GV Glinsky, K Rittenhouse-Olson, ME Huflejt, OV Glinskii, ...
Cancer research 61 (12), 4851-4857, 2001
3022001
Modified citrus pectin anti-metastatic properties: one bullet, multiple targets
VV Glinsky, A Raz
Carbohydrate research 344 (14), 1788-1791, 2009
2822009
MDA-MB-435 human breast carcinoma cell homo-and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions
SK Khaldoyanidi, VV Glinsky, L Sikora, AB Glinskii, VV Mossine, TP Quinn, ...
Journal of Biological Chemistry 278 (6), 4127-4134, 2003
2102003
Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs
OV Glinskii, VH Huxley, GV Glinsky, KJ Pienta, A Raz, VV Glinsky
Neoplasia 7 (5), 522-527, 2005
2032005
Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on β-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast …
VV Glinsky, ME Huflejt, GV Glinsky, SL Deutscher, TP Quinn
Cancer research 60 (10), 2584-2588, 2000
1972000
Peptides specific to the galectin-3 carbohydrate recognition domain inhibit metastasis-associated cancer cell adhesion
J Zou, VV Glinsky, LA Landon, L Matthews, SL Deutscher
Carcinogenesis 26 (2), 309-318, 2005
1822005
Resistance to apoptosis in human cells conferred by telomerase function and telomere stability
SE Holt, VV Glinsky, AB Ivanova, GV Glinsky
Molecular carcinogenesis 25 (4), 241-248, 1999
1681999
Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms
GV Glinsky, VV Glinsky, AB Ivanova, CJ Hueser
Cancer letters 115 (2), 185-193, 1997
1661997
Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death
GV Glinsky, VV Glinsky
Cancer letters 101 (1), 43-51, 1996
1291996
Identification and characterization of peptides that bind human ErbB-2 selected from a bacteriophage display library
NG Karasseva, VV Glinsky, NX Chen, R Komatireddy, TP Quinn
Journal of protein chemistry 21 (4), 287-296, 2002
1232002
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia
KD Johnson, OV Glinskii, VV Mossine, JR Turk, TP Mawhinney, ...
Neoplasia 9 (8), 662-670, 2007
1212007
Inhibition of Spontaneous Breast Cancer Metastasis by Anti—Thomsen-Friedenreich Antigen Monoclonal Antibody JAA-F11
J Heimburg, J Yan, S Morey, OV Glinskii, VH Huxley, L Wild, R Klick, ...
Neoplasia 8 (11), 939-948, 2006
1062006
Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines
GV Glinsky, JE Price, VV Glinsky, VV Mossine, G Kiriakova, JB Metcalf
Cancer research 56 (23), 5319-5324, 1996
1061996
Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine
OV Glinskii, S Sud, VV Mossine, TP Mawhinney, DC Anthony, GV Glinsky, ...
Neoplasia 14 (1), 65-73, 2012
772012
Characterization of peptides that bind the tumor-associated Thomsen-Friedenreich antigen selected from bacteriophage display libraries
EN Peletskaya, VV Glinsky, GV Glinsky, SL Deutscher, TP Quinn
Journal of molecular biology 270 (3), 374-384, 1997
761997
Synthetic galectin-3 inhibitor increases metastatic cancer cell sensitivity to taxol-induced apoptosis in vitro and in vivo
VV Glinsky, G Kiriakova, OV Glinskii, VV Mossine, TP Mawhinney, JR Turk, ...
Neoplasia 11 (9), 901-909, 2009
712009
Evidence of porcine and human endothelium activation by cancer‐associated carbohydrates expressed on glycoproteins and tumour cells
OV Glinskii, JR Turk, KJ Pienta, VH Huxley, VV Glinsky
The Journal of physiology 554 (1), 89-99, 2004
582004
Anti-Thomsen-Friedenreich-Ag (anti-TF-Ag) potential for cancer therapy
A Almogren, J Abdullah, K Ghapure, K Ferguson, VV Glinsky, ...
Front Biosci (Schol Ed) 4, 840-863, 2012
482012
Development, characterization, and immunotherapeutic use of peptide mimics of the Thomsen-Friedenreich carbohydrate antigen
J Heimburg-Molinaro, A Almogren, S Morey, OV Glinskii, R Roy, ...
Neoplasia 11 (8), 780-792, 2009
462009
The system can't perform the operation now. Try again later.
Articles 1–20